NK cells play a crucial role in tumor immunosurveillance with a unique capacity of killing cancer cells via antibody dependent cellular cytotoxicity (ADCC), particularly in the setting of head and neck cancer (HNC) where cetuximab, an EGFR-specific mAb, has been used since 2006. The gene discussed is EGFR; the disease is neoplasm.